Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Diversity, Equity, and Inclusion in Physical Therapy

Feb 1, 2021/Feature

APTA expands efforts to make the profession inclusive, welcoming, and accessible to all.

Understanding Targeted Probe and Educate

Jul 1, 2018/Column

This CMS program is designed to help providers and suppliers reduce claim denials and appeals. Here's what to know if you're contacted.

Combined Sections Meeting: Better Together and Bigger Than Ever

May 1, 2018/Feature

The Combined Sections Meeting brought more than 17,000 people to New Orleans-yet another record-breaking attendance for the annual conference of the association’s 18 specialty sections.

Providing Offsite Wellness Services

May 9, 2020/Column

What you need to know about offering health and wellness services at gyms and public pools.

APTA's Brand: Adding Value to Membership and the Profession

Oct 1, 2020/Feature

Less than four months in, APTA’s unified brand initiative is producing results.

APTA Insights: Proposed Rule Comments

Aug 1, 2022/Column

How to Draft Effective Regulatory Comments to Support Physical Therapy

Study: Starting Physical Therapy on Surgery Day Tied to Shorter Hospital Stays

Dec 7, 2022/Review

Geriatric hip fracture surgery patients who started PT services on the day of surgery or one day later also had lower mortality.

2021 Lynda D. Woodruff Lecture

Jun 17, 2021/Video

Improving diversity, equity, and inclusion within the field of physical therapy has taken many challenges.

APTA Statement on Peterson Health Technology Institute's Report on Virtual Musculoskeletal Solutions Health Technology Assessment

Jun 5, 2024/Statement

The following statement was released today by American Physical Therapy Association President Roger Herr, PT, MPA.

EULAR Recommendations for the Non-Pharmacological Core Management of Hip and Knee Osteoarthritis: 2023 Update

May 15, 2024/CPG

These updated multidisciplinary recommendations focus on the nonpharmacological management of hip and knee osteoarthritis (OA).